Medtronic Reports Third Quarter Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/25/2026
Go back to Medtronic Reports Third Quarter Financial Results
March 2, 2016 6:41 AM EST
Leerink Partners analyst, Danielle Antalffy, cut her PT on Medtronic (NYSE: MDT) as sales growth was offset by weaker margins. PT goes to $82 from $84 and Market Perform rating remains unchanged.
MDT shares traded lower yesterday driven by less positive operating leverage than expected, as... More
March 1, 2016 3:02 PM EST
Deutsche Bank earlier reiterated a Buy rating on Medtronic, Inc. (NYSE: MDT) with a price target of $90. Analyst Kristen Stewart said investors should buy weakness.
The analyst explained, "We continue to rate MDT a Buy. Why? We see a number of recently and... More
March 1, 2016 11:50 AM EST
Needham & Company maintained a Buy rating on Medtronic, Inc. (NYSE: MDT), and cut the price target to $88.00 (from $91.00), following the company's 3Q earnings report. Revenue was reported at $6.934B vs. the consensus of $6.987B. Adjusted EPS was reported at $1.06, in-line with consensus estimates. MDT... More
March 1, 2016 6:47 AM EST
Medtronic (NYSE: MDT) reported Q3 EPS of $1.06, in-line with the analyst estimate of $1.06. Revenue for the quarter came in at $6.93 billion versus the consensus estimate of $6.99 billion.
GUIDANCE:
Medtronic still sees FY16 EPS of $4.36 - $4.40, versus the consensus of $4.38.
For earnings history and earnings-related data on Medtronic (MDT) click here.
...
More
